Strategic partnerships Opportunity to deepen collaboration with medical device manufacturers through the newly formed West Coast Device Alliance (WCDA), offering PBL’s GMP/GLP testing and biocompatibility services as a trusted QA and regulatory-compliant partner in the device development lifecycle.

Regulatory leadership Leverage PBL’s established quality culture and 25-year SOT Exhibit leadership to position the company as a premier provider for complex toxicology, biocompatibility, and sterility testing, targeting sponsors seeking robust regulatory support and uninterrupted client service.

Expanded service lines Cross-sell opportunities from the In Vitro Sciences platform into core CRO services, enabling end-to-end testing solutions (analytical chemistry, microbiology, toxicology) for pharma, biotech, and medical device clients seeking streamlined, single-vendor workflows.

Geographic focus Capitalize on West Coast footprint and industry clusters to win regional accounts, emphasizing proximity for faster turnaround, ongoing quality assurance, and ease of collaboration with West Coast device and biotech firms aligned with WCDA priorities.

Technology-enabled outreach Utilize existing tech stack (HubSpot, ActiveCampaign, analytics, cloud) to run targeted campaigns highlighting rapid onboarding, personalized service, and strict regulatory compliance—driving higher engagement with decision-makers in medical devices and regulated biopharma.